Herein, we sought to discuss the current understanding of the molecular mechanisms of NF‐κB in diverse glioma microenvironments such as hypoxia, inflammation and oxidative stress, and its function as a therapeutic target for antiangiogenic strategies aimed at glioma. The gene discussed is NFKB1; the disease is central nervous system cancer.